Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Infect Genet Evol ; 75: 103981, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31369863

RESUMEN

Peste des petits ruminants virus (PPRV) is a morbillivirus which causes severe disease in ruminants. Since interferons (IFNs) serve as the important defense line against viral infection, we have investigated the roles of types I and III IFNs in PPRV infection in vitro. Upon PPRV infection, IFN-λ3 was strongly induced, while IFN-ß and IFN-λ2 were moderately induced at transcriptional level in human embryonic kidney 293 T (HEK293T) cells. Although the transcription of type I and III IFNs were triggered, the production of functional IFN products was not detected. Importantly, the replication of PPRV was strongly inhibited in HEK293T cells treated by the exogenous IFNs (IFN-α-2b, IFN-ß and IFN-λ3). Consistently, these IFNs significantly activate a panel of IFN-stimulated genes (ISGs). The inhibition of JAK-STAT pathway by JAK I inhibitor can abrogate the anti-PPRV activity of IFNs. Thus, our study shall contribute to better understanding of the complex PPRV-host interactions and provide rationale for therapeutic development of IFN-based treatment against PPRV infection.


Asunto(s)
Interferones/genética , Interferones/farmacología , Peste de los Pequeños Rumiantes/genética , Virus de la Peste de los Pequeños Rumiantes/fisiología , Animales , Regulación de la Expresión Génica/efectos de los fármacos , Células HEK293 , Interacciones Microbiota-Huesped , Humanos , Quinasas Janus/genética , Peste de los Pequeños Rumiantes/tratamiento farmacológico , Peste de los Pequeños Rumiantes/virología , Virus de la Peste de los Pequeños Rumiantes/efectos de los fármacos , Factores de Transcripción STAT/genética , Transducción de Señal/efectos de los fármacos , Replicación Viral/efectos de los fármacos
2.
Infect Genet Evol ; 11(7): 1727-31, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21784172

RESUMEN

To analyze the changes that occur in pigs during hepatitis E virus (HEV) infection, 256 serial serum samples were obtained from 32 pigs from one pig farm at ages 0 (cord blood), 15, 30, 60, 75, 90, 120, and 150 days. All HEV markers were assayed in these samples and showed that total anti-HEV antibodies and IgG formed two peaks. The first peak occurred at 0-60 days and the second after 75 days. No markers of infection, such as HEV RNA, antigen and anti-HEV IgM, were detectable during the first peak. Most newborn piglets (< 24 h of age) were negative for total anti-HEV and IgG. However, colostrum from all of the sows had evidence of these antibodies. Thus, the anti-HEV in the first peak was assumed to be acquired from maternal milk. Some infectious markers were positive at the beginning of second peak. PCR products were cloned and sequenced and the results indicated those sequences belonged to HEV genotype 4. The antibody present during the second peak may be induced by natural infection with HEV. In conclusion, pigs are susceptible to HEV infection and may remain infectious after the first peak of anti-HEV antibody.


Asunto(s)
Hepatitis E/veterinaria , Enfermedades de los Porcinos/virología , Animales , Animales Recién Nacidos , China , Calostro/inmunología , Femenino , Anticuerpos Antihepatitis/sangre , Antígenos de la Hepatitis/sangre , Hepatitis E/inmunología , Hepatitis E/virología , Virus de la Hepatitis E/clasificación , Virus de la Hepatitis E/genética , Virus de la Hepatitis E/inmunología , Interacciones Huésped-Patógeno/inmunología , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Filogenia , Embarazo , ARN Viral/sangre , ARN Viral/genética , Sus scrofa , Porcinos , Enfermedades de los Porcinos/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA